Skip to main content
HairCited

Микронидлинг для Alopecia Areata

A

На основе 32 исследований (1 meta-analysis, 9 RCTs) с участием 1,908 участников. 25/32 исследований показывают положительные эффекты.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Итог

Microneedling has strong evidence for supporting hair regrowth in alopecia areata, especially when combined with topical medications, and is backed by multiple randomized controlled trials.

  • 25 out of 32 studies show positive effects, with 9 RCTs providing robust evidence
  • Works by creating micro-injuries that stimulate healing responses and improve drug absorption
  • Most effective when combined with topical agents like corticosteroids or vitamin D3
  • Both professional clinical procedures and at-home derma rollers have been studied

Key Study Findings

scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) или: Placebo Эффект: None None
retrospective cohort n=7 Open-label
Combination Therapy With CGF and Microneedling-Assisted Compound Betamethasone for Resistant Alopecia Areata: A Pilot Study.
Dose: Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip или: Placebo Эффект: 85.7% achieved complete recovery; 14.3% achieved >50% regrowth; significant SALT score improvement None
randomized controlled trial n=24 18 weeks Open-label
A Comparative Clinical and Trichoscopic Study Between Fractional Radiofrequency Microneedling Versus Intralesional Steroids in Treatment …
Dose: Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals или: Placebo Эффект: Comparable efficacy between FRM and ILCS; nonsignificant differences in trichoscopic scores, PGA, an None
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera или: Placebo Эффект: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
animal study 2 weeks
Investigating the potential mechanism of microneedling in alopecia areata mice based on 16S rRNA sequencing …
Dose: Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment или: Placebo Эффект: Microneedling enhanced hair growth; restored gut microbiome diversity; reduced acetic acid and propa None

Key Statistics

34

Исследования

1908

Участники

Positive

A

Оценка

Referenced Papers

Cureus 2025 7 цитирований
Lasers in medical … 2024 10 цитирований
Skin appendage disorders 2024 5 цитирований
The Journal of … 2024 2 цитирований
Dermatology and therapy 2022 43 цитирований
Journal of the … 2020 10 цитирований
Proceedings (Baylor University. … 2020 8 цитирований
Journal of the … 2018 114 цитирований
Journal of cutaneous … 2014 80 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

hairloss:
1.5 mm depth, weekly sessions

Верхний предел: Not applicable

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip -- Positive 7
None -- Mixed --
Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals 18 weeks Neutral 24
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment 2 weeks Positive --
Microinfusion of medications into the skin (MMP) using tattoo devices; various drugs (minoxidil, ste -- Positive --
Melatonin 3 mg/kg; PBM diode laser 660nm, 100mW, 3 J/point, 2 sessions/week 12 weeks Mixed 60

Лучшее время приёма: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

Известные взаимодействия

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

Допустимый верхний уровень потребления: Not applicable

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Микронидлинг help with Alopecia Areata?
Based on 34 studies with 1,908 participants, there is strong evidence from multiple clinical trials that Микронидлинг may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Микронидлинг should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Микронидлинг?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Микронидлинг and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 34 peer-reviewed studies with 1,908 total participants. The overall direction of effect is positive.

Related Evidence

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.